Edition:
United States

Cipla Ltd (CIPL.BO)

CIPL.BO on Bombay Stock Exchange

608.65INR
17 Nov 2017
Change (% chg)

Rs15.65 (+2.64%)
Prev Close
Rs593.00
Open
Rs605.00
Day's High
Rs614.50
Day's Low
Rs601.20
Volume
103,288
Avg. Vol
112,282
52-wk High
Rs663.00
52-wk Low
Rs479.00

Latest Key Developments (Source: Significant Developments)

Cipla gets final approval for generic Pulmicort Respules
Thursday, 16 Nov 2017 10:25pm EST 

Nov 17 (Reuters) - Cipla Ltd ::Cipla receives final approval for generic Pulmicort Respules.Drug indicated for maintenance treatment of asthma, as prophylactic therapy in children 12 months to 8 years of age.Product available for shipping immediately.  Full Article

India's Cipla Sept qtr consol profit up about 19 pct
Tuesday, 7 Nov 2017 03:26am EST 

Nov 7 (Reuters) - Cipla Ltd :Sept quarter consol net profit 4.23 billion rupees versus profit of 3.54 billion rupees last year.Consensus forecast for sept quarter consol net profit was 4.20 billion rupees.Sept quarter consol net sales 39.88 billion rupees versus 36.72 billion rupees last year.  Full Article

Cipla says US unit gets USFDA final approval for generic Renvela tablets‍​
Friday, 27 Oct 2017 01:23am EDT 

Oct 27 (Reuters) - Cipla Ltd :Says us subsidiary receives final approval for generic Renvela tablets‍​.  Full Article

Cipla's U.S. unit gets final FDA nod for generic Renvela tablets
Thursday, 26 Oct 2017 11:26pm EDT 

Oct 27 (Reuters) - Cipla Ltd ::Says co's U.S. unit gets final FDA nod for generic Renvela tablets ‍​.  Full Article

Cipla says co on target to ramp-up launch trajectory in U.S.‍​
Friday, 11 Aug 2017 04:19am EDT 

Aug 11 (Reuters) - Cipla Ltd :Says "we are on target to ramp-up our launch trajectory in the U.S.”‍​.  Full Article

India's Cipla June-qtr consol profit up about 21 pct
Friday, 11 Aug 2017 04:09am EDT 

Aug 11 (Reuters) - Cipla Ltd :June quarter consol net profit 4.09 billion rupees versus 3.39 billion rupees last year.Consensus forecast for june quarter consol net profit was 3 billion rupees.June quarter consol net sales 34.32 billion rupees versus 35.56 billion rupees last year.  Full Article

India's Cipla launches rectal artesunate suppositories for severe malaria in young children
Tuesday, 25 Jul 2017 06:04am EDT 

July 25 (Reuters) - Cipla Ltd :Launches quality-assured rectal artesunate suppositories for severe malaria in young children.Says co's RAS product will now soon be available in four sub-Saharan countries.  Full Article

Perrigo announces settlement of generic version of dymista nasal spray patent litigation
Monday, 17 Jul 2017 09:06am EDT 

July 17 (Reuters) - Perrigo Company Plc ::Perrigo announces settlement of generic version of dymista nasal spray patent litigation.Perrigo Company Plc - ‍settled hatch-waxman litigation relating to dymista nasal spray brought by MEDA Pharmaceuticals Inc and Cipla Ltd​.  Full Article

Cipla exec expects to file for approval of more than 20 products in the U.S. in FY18
Thursday, 25 May 2017 07:55am EDT 

May 25 (Reuters) - Cipla Ltd : :Cipla exec says remodelling Cipla Biotec towards an in-licensing structure.Cipla exec says plan to be very active on in-licensing opportunities.Cipla exec says expects to file for approval of more than 20 products in the U.S. in FY18.Cipla exec says memorandum of understanding signed for a South Africa plant signed last year is on hold.Cipla exec says expects volatility in India market in coming months due to GST.  Full Article

Cipla U.S. arm signs worldwide licensing deal with MEDRx
Thursday, 6 Apr 2017 03:22am EDT 

Cipla Ltd : Says Cipla USA enters into collaboration with Medrx . Medrx is eligible to receive up to USD 30 million cumulatively through upfront and developmental, regulatory, and commercial milestones payments . Medrx will also receive tiered royalties on the net sales of commercialized licensed products .Worldwide licensing agreement (except for east asia) signed for development, commercialize of mrx-4tzt, a tizanidine1 patch for spasticity.  Full Article

Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Nov 17 Indian private sector lenders Yes Bank Ltd and IndusInd Bank Ltd will join the BSE stock exchange's 30-member Sensex index, effective Dec. 18, the index provider said on Friday.